NYSE - Nasdaq Real Time Price • USD
Encompass Health Corporation (EHC)
As of 3:54 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 11 |
| Avg. Estimate | 1.01 | 0.96 | 4.09 | 4.58 |
| Low Estimate | 0.95 | 0.9 | 3.92 | 4.27 |
| High Estimate | 1.06 | 1 | 4.31 | 4.98 |
| Year Ago EPS | 0.95 | 0.86 | 3.64 | 4.09 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | 1.31B | 1.32B | 5.31B | 5.78B |
| Low Estimate | 1.29B | 1.32B | 5.25B | 5.71B |
| High Estimate | 1.32B | 1.34B | 5.34B | 5.88B |
| Year Ago Sales | -- | -- | 4.8B | 5.31B |
| Sales Growth (year/est) | -- | -- | 10.50% | 8.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.74 | 0.77 | 0.82 | 0.94 |
| EPS Actual | 0.95 | 0.86 | 0.95 | 1.12 |
| Difference | 0.21 | 0.09 | 0.13 | 0.18 |
| Surprise % | 28.40% | 11.70% | 15.90% | 19.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.01 | 0.96 | 4.09 | 4.58 |
| 7 Days Ago | 1.01 | 0.96 | 4.09 | 4.58 |
| 30 Days Ago | 1.02 | 0.98 | 3.96 | 4.4 |
| 60 Days Ago | 1.02 | 0.98 | 3.96 | 4.4 |
| 90 Days Ago | 1.01 | 0.99 | 3.95 | 4.38 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | 3 | 3 | 10 | 10 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EHC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 6.30% | -- | -- | 8.30% |
| Next Qtr. | 11.60% | -- | -- | 11.90% |
| Current Year | 12.40% | -- | -- | 5.60% |
| Next Year | 12.00% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 14.74% | -- | -- | 11.05% |
| Past 5 Years (per annum) | 2.07% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Raymond James: Strong Buy to Strong Buy | 4/26/2024 |
| Maintains | Barclays: Overweight to Overweight | 4/25/2024 |
| Maintains | Mizuho: Buy to Buy | 4/25/2024 |
| Maintains | Barclays: Overweight to Overweight | 3/28/2024 |
| Initiated | Barclays: Overweight | 3/6/2024 |
| Maintains | Truist Securities: Buy to Buy | 2/9/2024 |
Related Tickers
EHAB Enhabit, Inc.
8.62
+3.36%
OPCH Option Care Health, Inc.
30.21
+0.30%
ENSG The Ensign Group, Inc.
117.73
-0.52%
CHE Chemed Corporation
570.40
-0.84%
ADUS Addus HomeCare Corporation
110.68
+1.30%
USPH U.S. Physical Therapy, Inc.
104.92
-1.38%
ACHC Acadia Healthcare Company, Inc.
71.42
-0.54%
PNTG The Pennant Group, Inc.
23.22
+2.56%
AMED Amedisys, Inc.
95.35
-0.16%
SEM Select Medical Holdings Corporation
33.80
+0.63%